Synaptogenix Inc (SNPX)

[kld2]

Don't have any human clinical data on efficacy. In fact, Neurotrope pr said there were no sign of cognitive improvement. And I know, I know: efficacy was only a secondary endpoint, and it was single dosing. My whole argument is the following: how can anyone claim that a drug has 80% chance of success when, clinically-speaking, it has had no success to data--that is, in the clinical, demonstrating efficacy. A bit optimistic, if you ask me.